Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Alternative energy -- Ignore unavailable to you. Want to Upgrade?

To: Jacob Snyder who wrote (11572)	8/22/2011 6:43:27 PM
From: Jacob Snyder	1 Recommendation Read Replies (2) \| Respond to of 16955

solar gross margins: 2010;2011 year;1Q,2Q,company (E = estimate) 46% 46% 37% FSLR 33% 27% 22% YGE 31% 27% 17%E TSL 29% 26% 25% JKS 23% 20% 03% SPWRA 22% 17% -3% JASO 22% 32% 02% LDK 17% 19% 04% STP 15% 15% 13% CSIQ 21% 16% ?? HSOL Since I posted 1Q11 results Message 27397504 the expected margin compression has been severe. The 4 stocks on my Buy List, had the highest margins for 2Q11. They were ahead; they are getting further ahead. And this list just includes Tier 1 big companies. In addition, there is a long list of Tier 2 and 3, whose results are worse than anything on this list. Current industry conditions cannot continue for more than 1 or 2 more quarters. Capacity is being taken out, companies are going bankrupt. Single-digit or negative gross margins for many companies are going to bring a dead halt to their expansion plans. Credit conditions are tightening all over the world, including in China. Companies dependent on borrowing or secondary stock offerings, are in serious trouble, especially if their debt is short-term. Once the industry gets through this painful phase, we'll see a few survivors dominating the industry. Poly and panel prices will stabilize, at prices low enough to cause a big increase in demand. LDK, which had surprisingly high margins in 1Q11, remains firmly off my Buy List, with its awful 2Q11 results, matching its awful balance sheet. SPWRA is showing that low manufacturing costs trump high efficiency, in this industry. They keep talking about their "brand name" and "high quality", and the Chinese keep taking market share. SPWRA is on the same road as Q-Cells: a dead end.